Incompetent
发表于 2025-3-25 05:26:09
http://reply.papertrans.cn/19/1879/187801/187801_21.png
BORE
发表于 2025-3-25 11:32:34
http://image.papertrans.cn/b/image/187801.jpg
Blazon
发表于 2025-3-25 11:43:38
https://doi.org/10.1007/978-0-387-79251-4Depression; affective disorders; biomarkers; diagnosis; genetics; neurological brain disorders; psychiatry
HPA533
发表于 2025-3-25 18:07:32
http://reply.papertrans.cn/19/1879/187801/187801_24.png
变异
发表于 2025-3-25 21:55:19
Neuroimaging Biomarkers in Schizophrenia,th genetic mapping techniques and the subsequent assessment of genomic variation (“imaging genetics”) has recently proved to be exceptionally powerful in advancing our understanding of the neural underpinnings of normal cognition and mental disease states. This upcoming research field has opened doo
涂掉
发表于 2025-3-26 00:09:12
Sleep EEG Provides Biomarkers in Depression,hanges in affective disorders include disinhibition of rapid-eye-movement (REM) sleep (shortened REM latency, prolonged first REM periods, elevated REM density, and a measure of the amount of REMs), impaired sleep continuity and changes of nonREM sleep (decreases of slow wave sleep and stage 2 sleep
积习已深
发表于 2025-3-26 07:25:42
http://reply.papertrans.cn/19/1879/187801/187801_27.png
旧病复发
发表于 2025-3-26 08:36:07
Book 2009biological markers are at hand that allow the physician to come up with a reliable diagnosis, there are currently no such markers available for affective disorders. As in any other disease area a major goal is therefore the identification of early markers that can categorize subsets of subjects in a
憎恶
发表于 2025-3-26 14:12:09
Book 2009athogenesis of the diseases and enhance our ability for treatment...This edited volume will not only address the area of affective disorders but also other brain disorders that are neurological in nature, including Multiple Sclerosis and Alzheimer Disease..
Laconic
发表于 2025-3-26 20:27:26
https://doi.org/10.1007/978-3-531-91798-6the current scientific knowledge on neuroimaging biomarkers in schizophrenia and illustrates the major conceptual change in the way in which biological intermediate phenotypes are viewed and pursued in psychiatry today.